🔗 Permalink

Inventor profile of:

Michael S. McGrath

City:

Burlingame, California

Country:

United States

Published Applications:

Last publication date:

2023-08-17

Top Assignees for applications by Michael S. McGrath

The entities that hold a legal rights for patent applications filed by inventor McGrath Michael S.:

The Regents of the University of California 5 Oakland, CA United States
Neuraltus Pharmaceuticals, Inc. 3 Palo Alto, CA United States
Pathlogica, LLC 2 San Francisco, CA United States
The Hospital for Sick Children 2 Toronto, Canada
Taiji Biomedical, Inc. 1 Menlo Park, CA United States
The Regents of the Univerity of California 1 Oakland, CA United States
The Hospital for Sick Children 1 , Canada
PATHOLOGICA LLC 1 Burlingame, CA United States

Recent patent applications by McGrath Michael S.

Michael S. McGrath from Burlingame, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-08-17

US20230256011A1

Human necessities

Chlorite In the Treatment of Acute Respiratory Distress Syndrome

#2 | 2019-02-28

US20190060359A1

Human necessities

TREATMENT OF NEURODEGENERATIVE DISEASE WITH SODIUM CHLORITE

#3 | 2017-04-20

US20170106017A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF MACROPHAGE-RELATED DISORDERS

#4 | 2017-03-09

US20170065634A1

Human necessities

Chlorite in the Treatment of Neurodegenerative Disease

#5 | 2015-07-23

US20150202185A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS

#6 | 2015-02-12

US20150044193A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION

#7 | 2015-02-05

US20150037320A1

Human necessities

Treatment of macrophage-related disorders

#8 | 2013-01-10

US20130012539A1

Human necessities

Compositions and methods for treating lysosomal disorders

#9 | 2012-11-22

US20120295296A1

Human necessities

Chlorite in the treatment of neurodegenerative disease

#10 | 2012-05-31

US20120134929A1

Human necessities

TREATMENT OF MACROPHAGE-RELATED DISORDERS

#11 | 2012-03-01

US20120052053A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION

#12 | 2012-01-26

US20120022166A1

Physics

Methods for Modulating Macrophage Proliferation Using Polyamine Analogs

#13 | 2011-04-21

US20110091418A1

Human necessities

METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS

#14 | 2011-03-03

US20110053186A1

Human necessities

Chlorite in the Treatment of Neurodegenerative Disease

#15 | 2009-06-25

US20090163500A1

Human necessities

Compositions and methods for treating lysosomal disorders

#16 | 2007-04-05

US20070078187A1

Human necessities

Methods for treating viral infections using polyamine analogs

#17 | 2006-07-20

US20060159775A1

Human necessities

Chlorite in the treatment of neurodegenerative disease

#18 | 2005-08-25

US20050186560A1

Chemistry; metallurgy

Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

#19 | 2005-08-18

US20050181068A1

Human necessities

Chlorite in the treatment of neurodegenerative disease

#20 | 2005-07-21

US20050159493A1

Physics

Methods for modulating macrophage proliferation using polyamine analogs

InventorID:

30076 ⎘